[Topical therapeutic action of a new preparation with antifungal and antibacterial action (Vancide 89 RE-BTC 2125 M 50%)].
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D001548:Benzalkonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D002215:Captan / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003881:Dermatomycoses / Q000188:drug therapy*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D000935:Antifungal Agents; D001548:Benzalkonium Compounds; D004338:Drug Combinations; D002215:Captan
Azione terapeutica topica di un nuovo preparato ad azione antifungina ed antibatterica (Vancide 89 RE-BTC 2125 M 50%).